Ananda Pharma (AQSE:ANA) Total Liabilities : £2.93 Mil (As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ananda Pharma Total Liabilities?

Ananda Pharma's Total Liabilities for the quarter that ended in Jul. 2023 was £2.93 Mil.

Ananda Pharma's quarterly Total Liabilities increased from Jul. 2022 (£3.15 Mil) to Jan. 2023 (£5.30 Mil) but then declined from Jan. 2023 (£5.30 Mil) to Jul. 2023 (£2.93 Mil).

Ananda Pharma's annual Total Liabilities increased from Jan. 2021 (£0.46 Mil) to Jan. 2022 (£2.08 Mil) and increased from Jan. 2022 (£2.08 Mil) to Jan. 2023 (£5.30 Mil).

Ananda Pharma Total Liabilities Historical Data

The historical data trend for Ananda Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Total Liabilities Chart

Ananda Pharma Annual Data

Trend

Jan19

Jan20

Jan21

Jan22

Jan23

Total Liabilities

0.02

0.19

0.46

2.08

5.30

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Total Liabilities	Get a 7-Day Free Trial						0.86	2.08	3.15	5.30	2.93

Ananda Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ananda Pharma's Total Liabilities for the fiscal year that ended in Jan. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.511	+	(0	+	0.793
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	5.30

Total Liabilities	=	Total Assets (A: Jan. 2023 )	-	Total Equity (A: Jan. 2023 )
	=	6.509	-	1.205
	=	5.30

Ananda Pharma's Total Liabilities for the quarter that ended in Jul. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.136	+	(0	+	0.793
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2.93

Total Liabilities	=	Total Assets (Q: Jul. 2023 )	-	Total Equity (Q: Jul. 2023 )
	=	7.772	-	4.843
	=	2.93

Ananda Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (AQSE:ANA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.anandapharma.co.uk

Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines